• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Manifest Learning Academy
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Science & Tech

Anti- COVID drug 2-deoxy-D-Glucose (2-DG)

June 30, 2021
in Science & Tech
Reading Time: 2 mins read
0
Anti- COVID drug 2-deoxy-D-Glucose (2-DG)
133
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook
image_pdfMake PDF

In news 

Anti- COVID drug 2-deoxy-D-Glucose (2-DG) has been launched commercially.

About Deoxy-D-Glucose (2-DG)

  • The anti-Covid therapeutic application of 2-DG has been jointly developed by:
    • The Institute of Nuclear Medicine and Allied Sciences.
    • Defence Research and Development Organisation (DRDO).
    • Dr Reddy’s Laboratories.
  • It received the nod(emergency use approval) of the Drug Controller General of India’s on May 1, 2021
  • It can be administered only upon prescription to hospitalised moderate to severe Covid-19 patients as an additional therapy to the existing care, under the supervision of a qualified physician.
  • The drug will be supplied to both Government and private Covid-19 health facilities across India.
  • Each sachet of 2-DG has been fixed at Rs 990 per sachet. The government institutions will receive at a subsidized rate.
  • The drug is available in powder form in a sachet, and can be taken orally after dissolving in water
  • The drug, 2-DB will be sold commercially under the brands 2DGTM.
  • According to Dr Reddy’s Laboratories,  the drug has a purity of 99.5 percent.
  •  Its selective accumulation in virally infected cells makes this drug unique. 
  • The drug reportedly reduces a patient’s average recovery time by two and a half days and oxygen demand by up to 40 per cent.
  • According to the government, 2-DG being a generic molecule and an analogue of glucose, it can be easily produced and made available in large quantities.

Who cannot use it(restricted usage)?

The 2DG should not be given to pregnant and lactating women and patients below 18 years.

The uncontrolled diabetes, severe cardiac problem, ARDS, severe hepatic and renal impairment patients have not been studied yet with 2DG, and hence caution should be exercised.

How does it work?

2-DG, made of the generic molecule along with an analogue of glucose, accumulates in the virus-infected cells of the body and prevents the invasion of the virus from one cell to another. Viral synthesis and energy production of the virus is cut short, stopping it from growing faster helping Covid patients to no longer depend on supplemental oxygen and recover faster.

image_pdfMake PDF
Source: Financial Express
Tags: News PaperPrelims

Related Posts

Breast tissue density’s role in detecting breast cancer

Breast tissue density’s role in detecting breast cancer

May 1, 2023
LUPEX mission

LUPEX mission

April 29, 2023
What is the Big Catch-up initiative?

What is the Big Catch-up initiative?

April 28, 2023
Shingrix vaccine

Shingrix vaccine

April 28, 2023
India’s first digital park

India’s first digital park

April 25, 2023
TeLEOS-2 and Lumelite-4

TeLEOS-2 and Lumelite-4

April 24, 2023
The State of the World’s Children 2023

The State of the World’s Children 2023

April 24, 2023
National Quantum Mission

National Quantum Mission

April 21, 2023
First test flight of SpaceX’s big Starship

First test flight of SpaceX’s big Starship

April 17, 2023
Bengaluru to get India’s 1st 3D printed post office

Bengaluru to get India’s 1st 3D printed post office

April 14, 2023
Please login to join discussion

Our Offline Classroom Student

CONGRATULATIONS TO 2021 TOPPERS !!!

Rank 171 Kumar Shivashish
Rank 250 Sahithya
Rank 263 Sumit Kumar Thakur
Rank 311 Deepak Ramachandra Shet
Rank 455 Ravinandan B M

June 2025
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« May    

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tags

AIR All India Radio BBC Business Line Business Standard dow Down to Earth DownToEarth DTE Economic Times ET FAO Financial Express GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express Indiatoday India today Kurukshetra Livelihoods portal LiveMint Mains News Newspaper News Paper PIB Prelims PRS India RSTV Science Reporter Survey The Hindu The India Express The Indian Express The Print the wire Times of India TOI TOPPERS Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tag

AIR All India Radio BBC Business Line Business Standard dow Down to Earth DownToEarth DTE Economic Times ET FAO Financial Express GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express Indiatoday India today Kurukshetra Livelihoods portal LiveMint Mains News Newspaper News Paper PIB Prelims PRS India RSTV Science Reporter Survey The Hindu The India Express The Indian Express The Print the wire Times of India TOI TOPPERS Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In